JP2022522942A5 - - Google Patents
Info
- Publication number
- JP2022522942A5 JP2022522942A5 JP2021539428A JP2021539428A JP2022522942A5 JP 2022522942 A5 JP2022522942 A5 JP 2022522942A5 JP 2021539428 A JP2021539428 A JP 2021539428A JP 2021539428 A JP2021539428 A JP 2021539428A JP 2022522942 A5 JP2022522942 A5 JP 2022522942A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- tumor
- formula
- inflammation
- related disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024139639A JP2024164126A (ja) | 2019-01-07 | 2024-08-21 | 有機化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789499P | 2019-01-07 | 2019-01-07 | |
| US62/789,499 | 2019-01-07 | ||
| PCT/US2020/012578 WO2020146384A1 (en) | 2019-01-07 | 2020-01-07 | Organic compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024139639A Division JP2024164126A (ja) | 2019-01-07 | 2024-08-21 | 有機化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022522942A JP2022522942A (ja) | 2022-04-21 |
| JP2022522942A5 true JP2022522942A5 (https=) | 2022-12-19 |
| JP7543278B2 JP7543278B2 (ja) | 2024-09-02 |
Family
ID=71520889
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539428A Active JP7543278B2 (ja) | 2019-01-07 | 2020-01-07 | 有機化合物 |
| JP2024139639A Pending JP2024164126A (ja) | 2019-01-07 | 2024-08-21 | 有機化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024139639A Pending JP2024164126A (ja) | 2019-01-07 | 2024-08-21 | 有機化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US12396992B2 (https=) |
| EP (1) | EP3908285A4 (https=) |
| JP (2) | JP7543278B2 (https=) |
| WO (1) | WO2020146384A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7134168B6 (ja) | 2016-09-12 | 2024-02-02 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規使用 |
| MX2020012628A (es) * | 2018-05-25 | 2021-01-29 | Intra Cellular Therapies Inc | Compuestos organicos. |
| WO2020146384A1 (en) * | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054853A (ko) | 2019-09-03 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치료 방법 |
| US12364695B2 (en) | 2020-06-02 | 2025-07-22 | Intra-Cellular Therapies, Inc. | Methods of treating inflammatory disease |
| MX2024010993A (es) * | 2022-03-11 | 2024-09-17 | Intra Cellular Therapies Inc | Compuestos organicos. |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4690935A (en) | 1983-03-31 | 1987-09-01 | Wayne State University | Inhibition of tumor growth and metastasis with calcium channel blocker compounds |
| AU2006255028B2 (en) * | 2005-06-06 | 2012-04-19 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20120012831A (ko) | 2007-12-06 | 2012-02-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| MA32942B1 (fr) | 2008-12-06 | 2012-01-02 | Intra Cellular Therapies Inc | Composes organiques |
| KR20110103949A (ko) | 2008-12-06 | 2011-09-21 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| WO2012177263A1 (en) | 2011-06-24 | 2012-12-27 | Intra-Cellular Therapies, Inc. | Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists |
| JP6224597B2 (ja) | 2011-09-27 | 2017-11-01 | バイオメッド バレー ディスカバリーズ，インコーポレイティド | グリオーマを処置するための組成物及び方法 |
| WO2013138118A1 (en) | 2012-03-14 | 2013-09-19 | The Regents Of The University Of California | Treatment of inflammatory disorders in non-human mammals |
| CA2877146C (en) | 2012-06-18 | 2020-10-20 | Dart Neuroscience (Cayman) Ltd | Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds |
| KR102240326B1 (ko) | 2013-03-15 | 2021-04-13 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| EP2968338B1 (en) | 2013-03-15 | 2019-01-09 | Intra-Cellular Therapies, Inc. | Pde1 inhibitors for use in the treatment and/or prevention of cns injuries, and pns diseases, disorders or injuries |
| JP6696904B2 (ja) | 2014-01-08 | 2020-05-20 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 製剤および医薬組成物 |
| EP3157926B1 (en) | 2014-06-20 | 2019-05-15 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US10131671B2 (en) | 2014-08-07 | 2018-11-20 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CA2961212C (en) | 2014-09-17 | 2024-02-06 | Intra-Cellular Therapies, Inc. | Compounds and methods |
| US10849862B2 (en) | 2014-12-26 | 2020-12-01 | Theravalues Corporation | Formulation of curcumin and anti-PD-1 antibody |
| JP2018515474A (ja) | 2015-04-28 | 2018-06-14 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 抗ｐｄ−１抗体を使用するｐｄ−ｌ１陽性黒色腫の処置 |
| CA2991628C (en) | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| JP7134168B6 (ja) | 2016-09-12 | 2024-02-02 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規使用 |
| WO2018093591A1 (en) | 2016-11-03 | 2018-05-24 | Juno Therapeutics, Inc. | Combination therapy of a cell based therapy and a microglia inhibitor |
| EP3558319A4 (en) | 2016-12-22 | 2020-07-22 | AbbVie Inc. | COMPOSITIONS AND PROCESSES FOR IMPROVING OR INCREASING THE PRODUCTION OF TYPE I IFN |
| TW201920104A (zh) | 2017-08-31 | 2019-06-01 | 美商馬愈法瑪公司 | 外核苷酸焦磷酸酶-磷酸二酯酶1(enpp-1)抑制劑及其用途 |
| MX2020012628A (es) | 2018-05-25 | 2021-01-29 | Intra Cellular Therapies Inc | Compuestos organicos. |
| US20210338679A1 (en) | 2018-09-25 | 2021-11-04 | Intra-Cellular Therapies, Inc. | Novel uses |
| WO2020146384A1 (en) * | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054853A (ko) | 2019-09-03 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치료 방법 |
| MX2024010993A (es) | 2022-03-11 | 2024-09-17 | Intra Cellular Therapies Inc | Compuestos organicos. |
-
2020
- 2020-01-07 WO PCT/US2020/012578 patent/WO2020146384A1/en not_active Ceased
- 2020-01-07 EP EP20738760.6A patent/EP3908285A4/en active Pending
- 2020-01-07 US US17/421,303 patent/US12396992B2/en active Active
- 2020-01-07 JP JP2021539428A patent/JP7543278B2/ja active Active
-
2024
- 2024-08-21 JP JP2024139639A patent/JP2024164126A/ja active Pending
-
2025
- 2025-07-16 US US19/271,087 patent/US20250339438A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522942A5 (https=) | ||
| US20240391884A1 (en) | Compounds and compositions for treating conditions associated with nlrp activity | |
| US11801316B2 (en) | Cromolyn derivatives and related methods of imaging and treatment | |
| JP2008520740A (ja) | Ｖｅｇｆ産生を阻害する活性因子としての置換されたフェノール | |
| AU2005228685A1 (en) | Hydrazide-containing CFTR inhibitor compounds and uses thereof | |
| US20220119429A1 (en) | Fluorine-containing compound and anti-cancer medical use thereof | |
| IL292457A (en) | Histone acetyl transferase activators, their preparations and their uses | |
| EA026674B1 (ru) | Соединения, применимые в качестве лекарственных средств | |
| CA2451932A1 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
| JP2016510764A (ja) | 混合系キナーゼ阻害剤および治療法 | |
| JP2004521866A (ja) | ニトロソジフェニルアミン誘導体 | |
| JP2020505356A5 (https=) | ||
| US20230192626A1 (en) | Novel soluble epoxide hydrolase inhibitors and method of use thereof | |
| KR20150031481A (ko) | 단백질 응집 저해제로서의 디- 및 트리-헤테로아릴 유도체 | |
| JP2024502175A5 (https=) | ||
| JP6159388B2 (ja) | タンパク質凝集の阻害剤としてのフェニル−尿素及びフェニル−カルバメート誘導体 | |
| WO2002076438A2 (en) | Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis | |
| JP2022546711A5 (https=) | ||
| JPWO2001036402A1 (ja) | 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体 | |
| US6919346B2 (en) | Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity | |
| US20040110757A1 (en) | Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis | |
| JP2025509446A5 (https=) | ||
| US6140362A (en) | Method for inhibiting the growth of mammalian cells | |
| JP2025003966A (ja) | キノンレダクターゼ２阻害剤化合物およびその使用 | |
| TW570796B (en) | Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of neurogenic inflammation |